Vivoryon Therapeutics N.V.

LSE:0R3M Stock Report

Market Cap: €54.3m

Vivoryon Therapeutics Management

Management criteria checks 1/4

Vivoryon Therapeutics' CEO is Frank Weber, appointed in Aug 2023, has a tenure of 1.25 years. total yearly compensation is €528.32K, comprised of 16.3% salary and 83.7% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth €70.78K. The average tenure of the management team and the board of directors is 6.1 years and 1.8 years respectively.

Key information

Frank Weber

Chief executive officer

€528.3k

Total compensation

CEO salary percentage16.3%
CEO tenure1.3yrs
CEO ownership0.1%
Management average tenure6.1yrs
Board average tenure1.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Frank Weber's remuneration changed compared to Vivoryon Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-€31m

Mar 31 2024n/an/a

-€30m

Dec 31 2023€528k€86k

-€28m

Compensation vs Market: Frank's total compensation ($USD559.78K) is above average for companies of similar size in the UK market ($USD356.13K).

Compensation vs Earnings: Insufficient data to compare Frank's compensation with company performance.


CEO

Frank Weber (64 yo)

1.3yrs

Tenure

€528,320

Compensation

Dr. Frank T. Weber M. D. has been Chief Medical and Development Officer (CMDO) of Vivoryon Vivoryon Therapeutics N. V. (formerly known as Vivoryon Therapeutics AG & Probiodrug AG) since September 1, 2019....


Leadership Team

NamePositionTenureCompensationOwnership
Frank Weber
Chairman of the Management Board1.3yrs€528.32k0.13%
€ 70.8k
Anne Doering
CSO & Investor Relations Officer1.3yrs€405.12kno data
Michael Schaeffer
Chief Business Officer6.1yrs€923.00kno data
Manuela Bader
Director of Investor Relations & Communicationsno datano datano data
Konrad Glund
Co-Founder & Advisorno data€222.11kno data
Hendrik Liebers
Advisorno data€319.20kno data

6.1yrs

Average Tenure

55yo

Average Age

Experienced Management: 0R3M's management team is seasoned and experienced (6.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Frank Weber
Chairman of the Management Board1.2yrs€528.32k0.13%
€ 70.8k
Anne Doering
CSO & Investor Relations Officer1.2yrs€405.12kno data
Michael Schaeffer
Chief Business Officerno data€923.00kno data
Erich Platzer
Independent Non-Executive Chairmanno data€246.00k1.36%
€ 741.0k
Charlotte Lohmann
Independent Non-Executive Directorno data€236.00kno data
Samir Shah
Independent Non-Executive Director2.4yrs€337.00kno data
Claudia Riedl
Independent Non-Executive Director2.4yrs€224.00k0.0038%
€ 2.1k

1.8yrs

Average Tenure

55yo

Average Age

Experienced Board: 0R3M's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.